StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note released on Saturday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance Shares of Brooklyn ImmunoTherapeutics stock opened at $1.56 on Friday. The firm has a fifty day moving average price of $1.83 and […]
StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report released on Friday. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Up 5.0 % BTX opened at $1.67 on Friday. The stock’s fifty day moving average is $1.81 and its two-hundred day moving average is […]
StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report released on Wednesday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance Shares of BTX opened at $1.64 on Wednesday. The stock’s 50-day simple moving average is $1.66 and its 200 day simple moving average […]
StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report issued on Tuesday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Down 1.7 % Brooklyn ImmunoTherapeutics stock traded down $0.03 during mid-day trading on Tuesday, reaching $1.76. The company had a trading volume of 2,368 […]
StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report published on Sunday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance NYSE BTX opened at $1.89 on Friday. The company has a market cap of $111.18 million, a P/E ratio of -0.83 and a beta […]